Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/139674
Immune response generated with the administration of autologous dendritic cells pulsed with an allogenic tumoral cell lines lysate in patients with newly diagnosed DIPG
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Background and objective. Diffuse intrinsic pontine glioma (DIPG) is a lethal brainstem tumor in children. Dendritic cells (DCs) have T-cell stimulatory capacity and, therefore, potential antitumor activity for disease control. DCs vaccines have been shown to reactivate tumor-specific T cells in both clinical and pre-clinical settings. We designed a phase Ib immunotherapy (IT) clinical trial with the use of autologous dendritic cells (ADCs) pulsed with an allogeneic tumors cell-lines lysate (ATCL) in patients with newly diagnosed DIPG after irradiation (RT). Methods. Nine patients with newly diagnosed DIPG met enrollment criteria. Autologous dendritic cell vaccines (ADCV) were prepared from monocytes obtained by leukapheresis. Five ADCV doses were administered intradermally during induction phase. In the absence of tumor progression, patients received 3 boosts of tumor lysate every three months during the maintenance phase. Results. Vaccine fabrication was feasible in all patients included in the study. Non-specific KLH (9/9 patients) and specific (8/9 patients) antitumor response was identified by immunologic studies in peripheral blood mononuclear cells (PBMC). Immunological responses were also confirmed in the T lymphocytes isolated from the cerebrospinal fluid (CSF) of 2 patients. Vaccine administration resulted safe in all patients treated with this schema. Conclusions. These preliminary results demonstrate that ADCV preparation is feasible, safe and generate a DIPG-specific immune response detected in PBMC and CSF. This strategy shows a promising backbone for future schemas of combination immunotherapy.
Matèries
Matèries (anglès)
Citació
Citació
BENÍTEZ-RIBAS, Daniel, CABEZÓN CABELLO, Raquel, FLÓREZ GRAU, Georgina, MOLERO, Mari carmen, PUERTA, Patricia, GUILLEN, Antonio, GONZÁLEZ-NAVARRO, Europa azucena, PACO MERCADER, Sonia, CARCABOSO, Ángel m., SANTA-MARIA LOPEZ, Vicente, CRUZ MARTÍNEZ, Ofelia, TORRES GÓMEZ-PALLETE, Carmen de, SALVADOR, Noelia, JUAN, Manel, MORA GRAUPERA, Jaume, MORALES LA MADRID, Andrés. Immune response generated with the administration of autologous dendritic cells pulsed with an allogenic tumoral cell lines lysate in patients with newly diagnosed DIPG. _Frontiers in Oncology_. 2018. Vol. 8, núm. 127. [consulta: 25 de febrer de 2026]. ISSN: 2234-943X. [Disponible a: https://hdl.handle.net/2445/139674]